Heather Eng
0000-0002-2914-3967
Pfizer
2 papers found
Refreshing results…
Disposition of Nirmatrelvir, an Orally Bioavailable Inhibitor of SARS-CoV-2 3C-Like Protease, across Animals and Humans
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
Missing publications? Search for publications with a matching author name.